Articles from UsAgainstAlzheimer's

UsAgainstAlzheimer's and CaringKind Collaborate to Offer Advocacy Opportunities for 100 Women of Impact
Collaboration gives 100 Women of Impact the option to engage in federal Alzheimer’s and dementia advocacy through UsAgainstAlzheimer’s.
By UsAgainstAlzheimer's · Via GlobeNewswire · August 31, 2026
New Report Offers Recommendations to Advance Brain Capital for Economic and Workforce Growth
The Business Collaborative for Brain Health calls on global leaders to invest in workforce brain capital
By UsAgainstAlzheimer's · Via GlobeNewswire · September 24, 2025
Houston Emerges as Global Center for Brain Health Innovation
Business and policy leaders outline plans to fuel workforce development and innovation in bid to accelerate $260 billion local GDP growth potential.
By UsAgainstAlzheimer's · Via GlobeNewswire · May 22, 2025
UPDATE: Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
WASHINGTON, Feb. 14, 2025 (GLOBE NEWSWIRE) -- A broad coalition of patient organizations today issued the following statement in response to cuts in staff, and research funding at federal agencies vital for American health.
By UsAgainstAlzheimer's · Via GlobeNewswire · February 14, 2025
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
WASHINGTON, Feb. 14, 2025 (GLOBE NEWSWIRE) -- A broad coalition of patient organizations today issued the following statement in response to cuts in staff, and research funding at federal agencies vital for American health.
By UsAgainstAlzheimer's · Via GlobeNewswire · February 14, 2025
Nine Levers Employers Can Use to Improve Brain Health and Workplace Performance
New unified model developed by UsAgainstAlzheimer's, the Davos Alzheimer's Collaborative and the McKinsey Health Institute provides roadmap for employers to promote employee brain health for better business outcomes
By UsAgainstAlzheimer's · Via GlobeNewswire · January 27, 2025
Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers
New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and productivity
By UsAgainstAlzheimer's · Via GlobeNewswire · September 19, 2024
UsAgainstAlzheimer’s Launches 2024 Brain Health Academy
Six new monthly sessions added to the free continuing education program for health and wellness professionals
By UsAgainstAlzheimer's · Via GlobeNewswire · April 16, 2024
Congress Passes Bills Making Major Investments in Alzheimer’s
Bill Increases Funding for Alzheimer’s Research and Prevention Efforts
By UsAgainstAlzheimer's · Via GlobeNewswire · March 23, 2024
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s
Agency to convene an advisory committee to consider the drug
By UsAgainstAlzheimer's · Via GlobeNewswire · March 8, 2024
Organizations Unite to Improve Brain Health
UsAgainstAlzheimer’s Launches Business Collaborative for Brain Health with founding partners AARP, GN Group, Eli Lilly, and Novo Nordisk, to improve brain health in the workforce.
By UsAgainstAlzheimer's · Via GlobeNewswire · February 8, 2024
Alzheimer’s Leaders Discuss How to Shift Science into Clinical Practice During National Alzheimer’s Summit
The event furthered discussions on ensuring recent scientific breakthroughs benefit patients.
By UsAgainstAlzheimer's · Via GlobeNewswire · October 20, 2023
UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
Medicare must now provide coverage for patients
By UsAgainstAlzheimer's · Via GlobeNewswire · July 6, 2023
Brain Health Academy Enrollment is Now Open, First Session Launches May 17
Free continuing education program for health and wellness professionals adds six new monthly sessions on modifiable risk factors including obesity, diabetes, hearing loss, depression, smoking, and alcohol use.
By UsAgainstAlzheimer's · Via GlobeNewswire · April 24, 2023
Sen. Collins, Rep. Eshoo Decry Medicare Coverage Rejection of Alzheimer’s Drugs
“It’s not CMS’ job to deny the use under the Medicare program of an FDA-approved drug.” – Sen. Susan Collins; “…breakthroughs have to reach people, otherwise it really doesn’t mean a darn thing to them.” – Rep. Anna Eshoo
By UsAgainstAlzheimer's · Via GlobeNewswire · October 18, 2022
TODAY: CMS Controversy, Rep. Eshoo, Nationally Recognized Scientists to Take Center Stage at UsAgainstAlzheimer’s National Summit
Two-day summit will feature panel conversations on the latest in Alzheimer’s prevention, early diagnosis, treatment, and equity with guests like Senator Collins and Congresswoman Anna Eshoo
By UsAgainstAlzheimer's · Via GlobeNewswire · October 12, 2022
Articles from UsAgainstAlzheimer's | Hannibal Courier - Post